PetMed Q4 sales $62.4M (-5% YoY), net loss $5.1M; acquires PetCareRx, declares $0.30 dividend

PETMED EXPRESS INC

2023-FY EPS reported $0.01 revenue$247,569,000

Q4 sales $62.4M (-5% YoY); net loss $5.1M ($0.25 loss per share) vs net income $6.1M last year.
Accrued $6.9M sales tax liability; adjusted EBITDA $3.6M vs $9.5M prior year.
New customers up 12% YoY to ~72,000; Autoship & Save revenue 44% of sales (vs 31% last year).
Completed PetCareRx acquisition for $36M cash; expects it to be accretive by end of fiscal year.
Declared $0.30 per share cash dividend payable in June 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

PETMED EXPRESS INC reported financial results for the fourth quarter and year ended on March 31, 2023.

Period: the fourth quarter and year ended on March 31, 2023
Result: reported results

Exact text from the filing

On May 22, 2023, PetMed Express, Inc. (the “Company”) held a conference call to discuss its financial results for the fourth quarter and year ended on March 31, 2023.

View on SEC.gov

38 earnings releases filed in the last 30 days. Browse all earnings releases →

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-23-000036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.